Senior regulatory and quality leadership, built inside the industries we now advise.

Consultant to blue-chip pharma. Former global quality lead at a FTSE 100 consumer business.

Senior regulatory and quality leader whose career spans consulting for blue-chip pharmaceutical multinationals and leading global quality operations for a FTSE 100 consumer goods business. Formally trained as a Responsible Person under UK GDP (Cogent Gold Standard accredited course) and now building practical, MHRA-aligned RP frameworks for UK operators. Hands-on background across GMP/GDP-regulated quality systems, supplier qualification, technical due diligence and operational delivery, applied to medicinal cannabis supply chains, controlled drug compliance and CBD novel foods.

Trusted by founders, boards and investors to bring structure, reduce delivery risk and move complex programmes forward, including market entry, international supply chain build, scale-up, turnaround and restructuring. Works selectively with compliance-focused founders building businesses designed to withstand regulatory scrutiny from day one. Strong at bridging regulators, technical teams, manufacturers and commercial stakeholders to convert strategy into executable, compliant plans.